BioDelivery Sciences jumps on Q3 beat

• BioDelivery Sciences (BDSI +7.8%) Q3 results:
• Revenues: $39.4M (+30%) in-line with consensus; product sales: $38.79M (+30.9%).
• Net income: $9.4M vs $0.35M a year ago; income/share: $0.09 vs $0 a year ago; non-GAAP net income: $12.7M vs $3.52M a year ago.
• Cash flow ops: $14M (+339.3%).
• EBITDA margin of 34% vs 11.6% a year ago.
• The board of directors authorized the repurchase of ~$25.0M of company's common stock and plans to utilize existing cash on hand to fund the share repurchase program.
• https://seekingalpha.com/news/3632287-biodelivery-sciences-jumps-8-on-q3-beat